Similarly, folate receptor-α (FRA) is overexpressed in lung cancer cells, allowing folic acid to be conjugated to nanoparticles encapsulating HuR siRNA for targeted delivery of FRA and accurate release of HuR siRNA. This evidence concerns the gene ELAVL1 and lung cancer.